Is Letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?

References

• Rodriguez-Wallberg KA, Oktay K. Fertility preservation in women with breast cancer. Clin Obstet Gynecol 2010;53:753–62
   PubMed Web of Science ®Google Scholar
• Sonmezer M, Oktay K. Fertility preservation in young women undergoing breast cancer therapy. Oncologist 2006;11:422–34
   PubMed Web of Science ®Google Scholar
• Revelli A, Molinari E, Salvagno F, et al. Oocyte cryostorage to preserve fertility in oncological patients. Obstet Gynecol Int 2012;2012:525896
   Google Scholar
• Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod Biomed Online 2011;23:314–22
   PubMed Web of Science ®Google Scholar
• ISFP Practice Committee, Kim SS, Donnez J, et al. Recommendations for fertility preservation in patients with lymphoma, leukemia, and breast cancer. J Assist Reprod Genet 2012;29:465–8
   Google Scholar
• Azim A, Oktay K. Letrozole for ovulation induction and fertility preservation by embryo cryopreservation in young women with endometrial carcinoma. Fertil Steril 2007;88:657–64
   PubMed Web of Science ®Google Scholar
• Azim AA, Costantini-Ferrando M, Oktay K. Safety of fertility preservation by ovarian stimulation with letrozole and gonadotropins in patients with breast cancer: a prospective controlled study. J Clin Oncol 2008;26:2630–5
   PubMed Web of Science ®Google Scholar
• Oktay K, Hourvitz A, Sahin G, et al. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 2006;91:3885–90
   PubMed Web of Science ®Google Scholar
• Ben-Haroush A, Farhi J, Ben-Aharon I, et al. High yield of oocytes without an increase in circulating estradiol levels in breast cancer patients treated with follicle-stimulating hormone and aromatase inhibitor in standard gonadotropin-releasing hormone analogue protocols. Isr Med Assoc J 2011;13:753–6
   PubMed Web of Science ®Google Scholar
• Badawy A, Abdel Aal I, Abulatta M. Clomiphene citrate or letrozole for ovulation induction in women with polycystic ovarian syndrome: a prospective randomized trial. Fertil Steril 2009;92:849–52
   PubMed Web of Science ®Google Scholar
• Badawy A, Mosbah A, Tharwat A, Eid M. Extended letrozole therapy for ovulation induction in clomiphene-resistant women with polycystic ovary syndrome: a novel protocol. Fertil Steril 2009;92:236–9
   PubMed Web of Science ®Google Scholar
• Verpoest WM, Kolibianakis E, Papanikolaou E, et al. Aromatase inhibitors in ovarian stimulation for IVF/ICSI: a pilot study. Reprod Biomed Online 2006;13:166–72
   PubMed Web of Science ®Google Scholar
• Papanikolaou EG, Polyzos NP, Humaidan P, et al. Aromatase inhibitors in stimulated IVF cycles. Reprod Biol Endocrinol 2011;9:85
   PubMedGoogle Scholar
• Requena A, Herrero J, Landeras J, et al. Use of letrozole in assisted reproduction: a systematic review and meta-analysis. Hum Reprod Update 2008;14:571–82
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Libertella N, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 2005;23:4347–53
   PubMed Web of Science ®Google Scholar
• Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum Reprod Update 2012;18:536–54
   PubMed Web of Science ®Google Scholar
• Oktay K. Further evidence on the safety and success of ovarian stimulation with letrozole and tamoxifen in breast cancer patients undergoing in vitro fertilization to cryopreserve their embryos for fertility preservation. J Clin Oncol 2005;23:3858–9
   PubMed Web of Science ®Google Scholar
• Oktay K, Buyuk E, Akar Z, et al. Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. Fertil Steril 2004;82:s1
   Google Scholar
• Checa Vizcaíno MA, Corchado AR, Sastre I, et al. The effects of letrozole on ovarian stimulation for fertility preservation in cancer-affected women. Reprod Biomed Online 2012;24:606–10
   PubMed Web of Science ®Google Scholar
• Levi Setti PE, Albani E, Novara PV, et al. Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 2006;21:370–5
   PubMed Web of Science ®Google Scholar
• Borini A, Levi Setti PE, Anserini P, et al. Multicenter observational study on slow-cooling oocyte cryopreservation: clinical outcome. Fertil Steril 2010;94:1662–8
   PubMed Web of Science ®Google Scholar
• Porcu E, Fabbri R, Damiano G, et al. Oocyte cryopreservation in oncological patients. Eur J Obstet Gynecol Reprod Biol 2004;113:S14–6
   Google Scholar
• Porcu E, Venturoli S, Damiano G, et al. Healthy twins delivered after oocyte cryopreservation and bilateral ovariectomy for ovarian cancer. Reprod BioMed Online 2008;17:265–267
   Google Scholar
• Porcu E, Ciotti MP, Venturoli S. Handbook of human oocyte cryopreservation. Cambridge, UK: Cambridge University Press; 2012
   Google Scholar
• Lee S, Oktay K. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer? Fertil Steril 2012;98:961–4
   PubMed Web of Science ®Google Scholar
• Domingo J, Guillén V, Ayllón Y, et al. Ovarian response to controlled ovarian hyperstimulation in cancer patients is diminished even before oncological treatment. Fertil Steril 2012;97:930–4
   PubMed Web of Science ®Google Scholar
• Almog B, Azem F, Gordon D, et al. Effects of cancer on ovarian response in controlled ovarian stimulation for fertility preservation. Fertil Steril 2012;98:957–60
   PubMedGoogle Scholar
• Germain D. Estrogen carcinogenesis in breast cancer. Endocrinol Metab Clin North Am 2011;40:473–84
   Google Scholar
• Chang M. Dual roles of estrogen metabolism in mammary carcinogenesis. BMB Rep 2011;44:423–34
   Google Scholar